These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26737551)

  • 1. Spatial distribution of nonlinear interactions in subthalamic nucleus local field potentials in Parkinson'S disease.
    Meloni G; Sen A; Abosch A; Ince NF
    Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():5557-60. PubMed ID: 26737551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encoding of sequence boundaries in the subthalamic nucleus of patients with Parkinson's disease.
    Herrojo Ruiz M; Rusconi M; Brücke C; Haynes JD; Schönecker T; Kühn AA
    Brain; 2014 Oct; 137(Pt 10):2715-30. PubMed ID: 25031238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency oscillations in the subthalamic nucleus: a neurophysiological marker of the motor state in Parkinson's disease.
    Özkurt TE; Butz M; Homburger M; Elben S; Vesper J; Wojtecki L; Schnitzler A
    Exp Neurol; 2011 Jun; 229(2):324-31. PubMed ID: 21376039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic nucleus phase-amplitude coupling correlates with motor impairment in Parkinson's disease.
    van Wijk BC; Beudel M; Jha A; Oswal A; Foltynie T; Hariz MI; Limousin P; Zrinzo L; Aziz TZ; Green AL; Brown P; Litvak V
    Clin Neurophysiol; 2016 Apr; 127(4):2010-9. PubMed ID: 26971483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic local field potentials in Parkinson's disease and isolated dystonia: An evaluation of potential biomarkers.
    Wang DD; de Hemptinne C; Miocinovic S; Qasim SE; Miller AM; Ostrem JL; Galifianakis NB; San Luciano M; Starr PA
    Neurobiol Dis; 2016 May; 89():213-22. PubMed ID: 26884091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of beta and high-frequency oscillations within the subthalamic nucleus region.
    van Wijk BCM; Pogosyan A; Hariz MI; Akram H; Foltynie T; Limousin P; Horn A; Ewert S; Brown P; Litvak V
    Neuroimage Clin; 2017; 16():175-183. PubMed ID: 28794978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease.
    López-Azcárate J; Tainta M; Rodríguez-Oroz MC; Valencia M; González R; Guridi J; Iriarte J; Obeso JA; Artieda J; Alegre M
    J Neurosci; 2010 May; 30(19):6667-77. PubMed ID: 20463229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic oscillations and phase amplitude coupling are greater in the more affected hemisphere in Parkinson's disease.
    Shreve LA; Velisar A; Malekmohammadi M; Koop MM; Trager M; Quinn EJ; Hill BC; Blumenfeld Z; Kilbane C; Mantovani A; Henderson JM; Brontë-Stewart H
    Clin Neurophysiol; 2017 Jan; 128(1):128-137. PubMed ID: 27889627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease.
    Zaidel A; Spivak A; Grieb B; Bergman H; Israel Z
    Brain; 2010 Jul; 133(Pt 7):2007-21. PubMed ID: 20534648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-frequency oscillations in Parkinson's disease: spatial distribution and clinical relevance.
    Wang J; Hirschmann J; Elben S; Hartmann CJ; Vesper J; Wojtecki L; Schnitzler A
    Mov Disord; 2014 Sep; 29(10):1265-72. PubMed ID: 25041924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying local field potential dynamics with amplitude and frequency stability between ON and OFF medication and stimulation in Parkinson's disease.
    Guo X; He S; Geng X; Yao P; Wiest C; Nie Y; Tan H; Wang S
    Neurobiol Dis; 2024 Jul; 197():106519. PubMed ID: 38685358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of Medication on the Oscillatory and Dynamic Characteristics of Subthalamic Local Field Potentials in Patients with Parkinson's Disease].
    Wang Y; Geng X; Huang Y; Wang S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Feb; 33(1):49-55. PubMed ID: 27382739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological recordings from electrodes implanted in the basal ganglia for deep brain stimulation in Parkinson's disease. the relevance of fast subthalamic rhythms.
    Foffani G; Ardolino G; Rampini P; Tamma F; Caputo E; Egidi M; Cerutti S; Barbieri S; Priori A
    Acta Neurochir Suppl; 2005; 93():97-9. PubMed ID: 15986736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A direct relationship between oscillatory subthalamic nucleus-cortex coupling and rest tremor in Parkinson's disease.
    Hirschmann J; Hartmann CJ; Butz M; Hoogenboom N; Ozkurt TE; Elben S; Vesper J; Wojtecki L; Schnitzler A
    Brain; 2013 Dec; 136(Pt 12):3659-70. PubMed ID: 24154618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain networks modulated by subthalamic nucleus deep brain stimulation.
    Accolla EA; Herrojo Ruiz M; Horn A; Schneider GH; Schmitz-Hübsch T; Draganski B; Kühn AA
    Brain; 2016 Sep; 139(Pt 9):2503-15. PubMed ID: 27412387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological gambling in Parkinson's disease: subthalamic oscillations during economics decisions.
    Rosa M; Fumagalli M; Giannicola G; Marceglia S; Lucchiari C; Servello D; Franzini A; Pacchetti C; Romito L; Albanese A; Porta M; Pravettoni G; Priori A
    Mov Disord; 2013 Oct; 28(12):1644-52. PubMed ID: 23554027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gait-related beta-gamma phase amplitude coupling in the subthalamic nucleus of parkinsonian patients.
    Farokhniaee A; Palmisano C; Del Vecchio Del Vecchio J; Pezzoli G; Volkmann J; Isaias IU
    Sci Rep; 2024 Mar; 14(1):6674. PubMed ID: 38509158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.
    Gulberti A; Moll CK; Hamel W; Buhmann C; Koeppen JA; Boelmans K; Zittel S; Gerloff C; Westphal M; Schneider TR; Engel AK
    Neuroimage Clin; 2015; 9():436-49. PubMed ID: 26594626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.
    Giannicola G; Marceglia S; Rossi L; Mrakic-Sposta S; Rampini P; Tamma F; Cogiamanian F; Barbieri S; Priori A
    Exp Neurol; 2010 Nov; 226(1):120-7. PubMed ID: 20713047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.